Castle Biosciences, Inc. Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Applied Molecular Transport...

Castle Biosciences (NASDAQ:CSTL) Director Joseph C. Cook III sold 2,108 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $39.00

Castle Biosciences (NASDAQ:CSTL) and Anpac Bio-Medical Science (NASDAQ:ANPC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the st

Canaccord Genuity analyst Max Masucci maintained a Buy rating on GenMark (GNMK – Research Report) yesterday and set a price

SKIN cancer symptoms most often develop on areas of the skin that have been exposed to the sun, but it can also develop on less obvious areas such as the feet. One sign of melanoma skin cancer - one o

Castle announced a change of location of its 2020 Annual Meeting of Stockholders to The San Luis Hotel, 5222 Seawall Blvd., Galveston, TX, 77550.

Castle Biosciences went public in July 2019 at $16.00 per share. The firm provides a variety of diagnostic and predictive testing for skin cancers. CSTL has imp

Castle announced publication of an intended use survey for DecisionDx®-SCC for patients diagnosed with high-risk cutaneous squamous cell carcinoma.

Castle announced publication of an intended use survey for DecisionDx®-SCC for patients diagnosed with high-risk cutaneous squamous cell carcinoma.

NYC Healthcare Heroes is expanding the program to deliver thousands of bags of food and supplies to over 5,000 EMS and disaster services workers.

CSTL earnings call for the period ending March 31, 2020.

The

Castle today announced its financial results for the first quarter ended March 31, 2020.

Castle today announced its financial results for the first quarter ended March 31, 2020.

The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...